198 related articles for article (PubMed ID: 33916787)
1. B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients.
Mendonça de Pontes R; Flores-Montero J; Sanoja-Flores L; Puig N; Pessoa de Magalhães RJ; Corral-Mateos A; Salgado AB; García-Sánchez O; Pérez-Morán J; Mateos MV; Burgos L; Paiva B; Te Marvelde J; van der Velden VHJ; Aguilar C; Bárez A; García-Mateo A; Labrador J; Leoz P; Aguilera-Sanz C; Durie B; van Dongen JJM; Maiolino A; Sobral da Costa E; Orfao A
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916787
[TBL] [Abstract][Full Text] [Related]
2. Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome.
Oliveira E; Costa ES; Ciudad J; Gaipa G; Sedek Ł; Barrena S; Szczepanski T; Buracchi C; Silvestri D; Siqueira PFR; Mello FV; Torres RC; Oliveira LMR; Fay-Neves IVC; Sonneveld E; van der Velden VHJ; Mejstrikova E; Ribera JM; Conter V; Schrappe M; van Dongen JJM; Land MGP; Orfao A;
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804860
[TBL] [Abstract][Full Text] [Related]
3. The
Vigliotta I; Armuzzi S; Barone M; Solli V; Pistis I; Borsi E; Taurisano B; Mazzocchetti G; Martello M; Poletti A; Sartor C; Rizzello I; Pantani L; Tacchetti P; Papayannidis C; Mancuso K; Rocchi S; Zamagni E; Curti A; Arpinati M; Cavo M; Terragna C
Front Oncol; 2022; 12():1001048. PubMed ID: 36276072
[TBL] [Abstract][Full Text] [Related]
4. Detailed immunophenotyping of B-cell precursors in regenerating bone marrow of acute lymphoblastic leukaemia patients: implications for minimal residual disease detection.
Theunissen PMJ; Sedek L; De Haas V; Szczepanski T; Van Der Sluijs A; Mejstrikova E; Nováková M; Kalina T; Lecrevisse Q; Orfao A; Lankester AC; van Dongen JJM; Van Der Velden VHJ;
Br J Haematol; 2017 Jul; 178(2):257-266. PubMed ID: 28419441
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G;
Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
[TBL] [Abstract][Full Text] [Related]
6. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.
van der Velden VH; Jacobs DC; Wijkhuijs AJ; Comans-Bitter WM; Willemse MJ; Hählen K; Kamps WA; van Wering ER; van Dongen JJ
Leukemia; 2002 Aug; 16(8):1432-6. PubMed ID: 12145681
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
Ciudad J; Orfao A; Vidriales B; Macedo A; Martínez A; González M; López-Berges MC; Valverde B; San Miguel JF
Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
[TBL] [Abstract][Full Text] [Related]
8. Flow Cytometric Analysis of Bone Marrow Particle Cells for Measuring Minimal Residual Disease in Multiple Myeloma.
Jiang D; Zhang Y; Tan S; Liu J; Li X; Zhang C
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230860
[TBL] [Abstract][Full Text] [Related]
9. [Clinical research on clearance of leukemic cell during induction of remission therapy in children with precursor B cell acute lymphoblastic leukemia].
Yi ZG; Cui L; Gao C; Jin M; Zhang RD; Li ZG; Wu MY
Zhonghua Er Ke Za Zhi; 2011 Mar; 49(3):170-4. PubMed ID: 21575363
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of both detection of lymphoblasts in the period of early treatment and minimal residual disease in childhood acute lymphoblastic leukemia].
Tie LJ; Gu LJ; Song DL; Jiang LM; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Wang YP; Chen J
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):6-9. PubMed ID: 15946500
[TBL] [Abstract][Full Text] [Related]
11. Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma.
Puig N; Flores-Montero J; Burgos L; Cedena MT; Cordón L; Pérez JJ; Sanoja-Flores L; Manrique I; Rodríguez-Otero P; Rosiñol L; Martínez-López J; Mateos MV; Lahuerta JJ; Bladé J; San Miguel JF; Orfao A; Paiva B
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638406
[TBL] [Abstract][Full Text] [Related]
12. Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma.
Flores-Montero J; Sanoja-Flores L; Paiva B; Puig N; García-Sánchez O; Böttcher S; van der Velden VHJ; Pérez-Morán JJ; Vidriales MB; García-Sanz R; Jimenez C; González M; Martínez-López J; Corral-Mateos A; Grigore GE; Fluxá R; Pontes R; Caetano J; Sedek L; Del Cañizo MC; Bladé J; Lahuerta JJ; Aguilar C; Bárez A; García-Mateo A; Labrador J; Leoz P; Aguilera-Sanz C; San-Miguel J; Mateos MV; Durie B; van Dongen JJM; Orfao A
Leukemia; 2017 Oct; 31(10):2094-2103. PubMed ID: 28104919
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL.
Lúcio P; Parreira A; van den Beemd MW; van Lochem EG; van Wering ER; Baars E; Porwit-MacDonald A; Bjorklund E; Gaipa G; Biondi A; Orfao A; Janossy G; van Dongen JJ; San Miguel JF
Leukemia; 1999 Mar; 13(3):419-27. PubMed ID: 10086733
[TBL] [Abstract][Full Text] [Related]
14. Understanding the reconstitution of the B-cell compartment in bone marrow and blood after treatment for B-cell precursor acute lymphoblastic leukaemia.
Theunissen PMJ; van den Branden A; Van Der Sluijs-Gelling A; De Haas V; Beishuizen A; van Dongen JJM; Van Der Velden VHJ
Br J Haematol; 2017 Jul; 178(2):267-278. PubMed ID: 28542787
[TBL] [Abstract][Full Text] [Related]
15. Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy.
van Lochem EG; Wiegers YM; van den Beemd R; Hählen K; van Dongen JJ; Hooijkaas H
Leukemia; 2000 Apr; 14(4):688-95. PubMed ID: 10764156
[TBL] [Abstract][Full Text] [Related]
16. No significant prognostic value of normal precursor B-cell regeneration in paediatric acute myeloid leukaemia after induction treatment.
Bras AE; van den Heuvel-Eibrink MM; van der Sluijs-Gelling AJ; Coenen EA; Wind H; Zwaan CM; te Marvelde JG; van der Burg M; Gibson B; Rijneveld AW; de Haas V; van Dongen JJ; van der Velden VH
Br J Haematol; 2013 Jun; 161(6):861-4. PubMed ID: 23577982
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
18. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation.
Seriu T; Yokota S; Nakao M; Misawa S; Takaue Y; Koizumi S; Kawai S; Fujimoto T
Leukemia; 1995 Apr; 9(4):615-23. PubMed ID: 7723394
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma.
Liu D; Lin P; Hu Y; Zhou Y; Tang G; Powers L; Medeiros LJ; Jorgensen JL; Wang SA
J Clin Pathol; 2012 Sep; 65(9):823-9. PubMed ID: 22685235
[TBL] [Abstract][Full Text] [Related]
20. Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index.
Óskarsson JÞ; Rögnvaldsson S; Thorsteinsdottir S; Aspelund T; Gunnarsson SB; Hákonardóttir GK; Sigurðardóttir GÁ; Þórðardóttir ÁR; Gíslason GK; Ólafsson A; Sigurðsson JK; Eyþórsson E; Jónsson Á; Viðarsson B; Önundarson PT; Agnarsson BA; Pálmason R; Sigurðardóttir M; Þorsteinsdóttir I; Ólafsson Í; Harding S; Flores-Montero J; Orfao A; Durie BGM; Love TJ; Kristinsson SY
Blood Cancer J; 2023 Dec; 13(1):177. PubMed ID: 38040702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
